Position in OVID
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$283,795
-$2,167,751 QoQ
Shares Held
105,500
-90.4% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 131 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. OVID ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in OVID
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,795 | 105,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,451,546 | 1,104,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,419,699 | 1,484,478 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,623,431 | 2,018,024 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $691,451 | 2,095,309 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $319,425 | 1,023,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $100,591 | 107,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $52,510 | 44,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $108,582 | 141,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $478,240 | 156,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $164,864 | 51,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $310,272 | 80,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $376,216 | 114,700 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $311,148 | 120,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $222,828 | 119,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $218,592 | 118,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $266,170 | 123,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $266,272 | 84,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $188,106 | 58,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $115,920 | 34,500 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $1,641,271 | 710,507 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $4,599,683 | 624,109 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,541,472 | 852,843 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||